Marketsby Five Percent Groupby The5ersTrade The PoolTrade The PoolMarketsby Five Percent Groupby The5ersTrade The PoolTrade The Pool
Live

GENB

Generate BiomedicinesNASDAQ · StockExchangeNASDAQ
$13.49−0.29 (−2.10%)US pre-market · opens in 4h 19m
At close
Free account:WatchlistPrice and earnings alertsTrade TalkNo trading account needed
Daily move−2.1%vs prev close $13.78
VolatilityVery highATR $0.98 · 7.3%
Gap %+1.3%Open vs prev close
52-week position21%of range $11.05–$22.55
Loading chart…

Why is GENB moving?

AI summary · updated 04:04 ET

GENB fell 2.1% as of the last close, underperforming the 1.32% market rise. With no news or events provided, the move appears mostly company-specific, with the decomposition showing -3.42 of specific pressure versus 1.32 from the market.

NoteNo news; mostly company-specific

Written by AI from 0 linked sources and refreshed as news lands. It can contain mistakes and is not investment advice.

Part of

Collections that include GENB

Investor holdings

Held by 4 of 50 tracked investors
13F · Q2 2026 · filed by Aug 14
2opened a position1added3trimmed or sold
ARK Investment ManagementCathie Wood · Growth manager0.1%$22MAdded +158%Renaissance TechnologiesJim Simons · Quant fund0.0%$669KNew positionMillennium ManagementIsrael Englander · Multi-strategy fund0.0%$370KTrimmed −94%Two Sigma InvestmentsJohn Overdeck & David Siegel · Quant fund0.0%$310KNew positionUS long positions only · filings lag the quarter end by up to 45 days · SEC EDGAR 13F · All tracked investors

Key stats

Stock
Open / Prev close
$13.96 / $13.78
Day range
$13.49 – $13.96
52-week range
$11.05 – $22.55
Volume
27.62K
ATR (14)
$0.98 · 7.3% · Very high
Gap %
+1.3%

SEC filings

All filings
Nov 5, 2026Disclosed a passive stake of 5% or morePassive stake · SEC EDGAR13GNov 4, 2026Insider trade reportedInsider trade · SEC EDGARForm 4Sep 3, 2026Insider trade reportedInsider trade · SEC EDGARForm 4Aug 25, 2026Regulation FD disclosureMaterial event · SEC EDGAR8-KAug 6, 2026Quarterly report filedQuarterly report · SEC EDGAR10-QAug 6, 2026Reported results of operationsMaterial event · SEC EDGAR8-K

About Generate Biomedicines

Generate Biomedicines is listed on NASDAQ and belongs to the null industry in the null sector.

Exchange
NASDAQ

GENB FAQ

Why is GENB stock moving today?

GENB fell 2.1% as of the last close, underperforming the 1.32% market rise.

How volatile is GENB?

GENB’s average true range over 14 days is $0.98, 7.3% of its price. That puts it in our very high volatility class.

Related news

All news
Best match for stocks

Put your GENB edge to the test with Trade The Pool

Stock-specific funded accounts. Trade US equities like GENB with firm capital and keep a share of the profits.